Return to all milestones

Industry unites to address COVID-19 crisis

The global pharmaceutical industry adopts a “business not as usual” approach, teaming up This link will open in a new window with biotechs, academia and “traditional” competitors to develop and scale-up COVID-19 vaccines, treatments and diagnostics.

The US government enforces the Defense Production Act This link will open in a new window, putting supply chains at risk. The industry calls to keep borders open and for free trade to continue, to allow the movement of raw materials, equipments and skilled workforce.

COVID-19 cases surpass 1 million. Ten days later, deaths pass 100,000 people. Countries start to be severely impacted by the effects of the pandemic, with the UN warning on the most certain socio-economic consequences This link will open in a new window, including the likely increase of poverty and inequalities worldwide.

Sanofi and GSK, two of the world's largest vaccines companies and competitors, sign a letter of intent This link will open in a new window to develop a COVID-19 vaccine together.

Incorporating 5,000 participants, the largest trial of COVID-19 drug treatments This link will open in a new window begins in the UK.

Germany grants Pfizer and BioNTech approvals This link will open in a new window to conduct the first clinical trial of their four COVID-19 vaccine candidates.